Glycogen Debranching Enzymes
Links shared publicly online about this topic
Glycogen Storage Disease, Type III: eMedicine Endocrinology
emedicine.medscape.com — “Overview: A glycogen storage disease (GSD) results from the absence of enzymes that ultimately convert glycogen compounds to glucose. Enzyme deficiency results in glycogen accumulation in tissues. In many cases, the defect has systemic consequences, but, in ...” View full resource at emedicine.medscape.com
Most Recently Shared on May 5, 2010 at 7:02 pm By:
Type III glycogen storage disease is also called Forbes-Cori disease, & is a result of debranching enzyme deficiecy. http://bit.ly/aGgc9e
Glycogen Storage Disease, Type Ib: eMedicine Endocrinology
emedicine.medscape.com — “Overview: A glycogen storage disease (GSD) is the result of an enzyme defect. These enzymes normally catalyze reactions that ultimately convert glycogen compounds to glucose. Enzyme deficiency results in glycogen accumulation in tissues. In many cases, the ...” View full resource at emedicine.medscape.com
Most Recently Shared on May 5, 2010 at 6:59 pm By:
Unfortunately, no specific treatment or cure exists for type Ib glycogen storage disease. Learn symptoms. http://bit.ly/cDomLM
Glycogen Storage Disease, Type IV: eMedicine Endocrinology
emedicine.medscape.com — “Overview: A glycogen storage disease (GSD) is the result of an enzyme defect. These enzymes normally catalyze reactions that ultimately convert glycogen compounds to glucose. Enzyme deficiency results in glycogen accumulation in tissues. In many cases, the ...” View full resource at emedicine.medscape.com
Most Recently Shared on May 5, 2010 at 7:03 pm By:
Type IV glycogen storage disease is also known as Andersen disease, and is a result of transglucosidase deficiency. http://bit.ly/boizB9
Glycogen Storage Disease, Type Ia: eMedicine Endocrinology
emedicine.medscape.com — “Overview: A glycogen storage disease (GSD) is the result of an enzyme defect. These enzymes normally catalyze reactions that ultimately convert glycogen compounds to glucose. Enzyme deficiency results in glycogen accumulation in tissues. In many cases, the ...” View full resource at emedicine.medscape.com
Most Recently Shared on May 5, 2010 at 6:58 pm By:
Type Ia glycogen storage disease can cause seizures or cardiomegaly. Learn more specifics. http://bit.ly/9dAIVV
Glycogen Storage Disease, Type VI: eMedicine Endocrinology
emedicine.medscape.com — “Overview: A glycogen storage disease (GSD) is the result of an enzyme defect. These enzymes normally catalyze reactions that ultimately convert glycogen compounds to glucose. Enzyme deficiency results in glycogen accumulation in tissues. In many cases, the ...” View full resource at emedicine.medscape.com
Most Recently Shared on May 5, 2010 at 7:06 pm By:
Hers disease, also called type VI glycogen storage disease, is characterized by phosphorylase deficiency. http://bit.ly/aBvj7k
Glycogen Storage Disease, Type V: eMedicine Endocrinology
emedicine.medscape.com — “Overview: A glycogen storage disease (GSD) is the result of an enzyme defect. These enzymes normally catalyze reactions that ultimately convert glycogen compounds to glucose. Enzyme deficiency results in glycogen accumulation in tissues. In many cases, the ...” View full resource at emedicine.medscape.com
Most Recently Shared on May 5, 2010 at 7:04 pm By:
McArdle disease, or type V glycogen storage disease is myophosphorylase deficiency. Learn more. http://bit.ly/cPhOaH
Glycogen Storage Disease, Type VII: eMedicine Endocrinology
emedicine.medscape.com — “Overview: A glycogen storage disease (GSD) is the result of an enzyme defect. These enzymes normally catalyze reactions that ultimately convert glycogen compounds to glucose. Enzyme deficiency results in glycogen accumulation in tissues. In many cases, the ...” View full resource at emedicine.medscape.com
Most Recently Shared on May 5, 2010 at 7:08 pm By:
Type VII glycogen storage disease is also called Tarui disease and is due to phosphofructokinase deficiency. Learn more.http://bit.ly/d8jUrn
Glycogen Storage Disease, Type II (Pompe Disease): eMedicine Endocrinology
emedicine.medscape.com — “Overview: A glycogen storage disease (GSD) is the result of an enzyme defect. These enzymes normally catalyze reactions that ultimately convert glycogen compounds to monosaccharides, of which glucose is the predominant component. Enzyme deficiency results in glycogen ...” View full resource at emedicine.medscape.com
Most Recently Shared on May 5, 2010 at 7:01 pm By:
Type II glycogen storage disease, or Pompe disease, is a result of acid maltase deficiency. More about type II GSD. http://bit.ly/bQYTVx
UCLA Researchers Uncover New Cell Biological Mechanism That Regulates Protein Stability In Cells
medicalnewstoday.com — “The cell signaling pathway known as Wnt, commonly activated in cancers, causes internal membranes within a healthy cell to imprison an enzyme that is vital in degrading proteins, preventing the e” View full resource at medicalnewstoday.com
Most Recently Shared on December 24, 2010 at 12:29 pm By:
UCLA Researchers Uncover New Cell Biological Mechanism That Regulates Protein Stability In Cells http://ow.ly/1aAKKY
Pompe Disease Information Page: National Institute of Neurological Disorders and Stroke (NINDS)
ninds.nih.gov — “Pompe disease-related neurological problems information sheet compiled by the National Institute of Neurological Disorders and Stroke (NINDS).” View full resource at ninds.nih.gov
Most Recently Shared on May 25, 2010 at 4:08 pm By:
LegalMedsDirect Health Business
What is Pompe Disease-http://tinyurl.com/yb5o69n
Start Of New Therapy For Late-Onset Pompe Patients In US
medicalnewstoday.com — “The first commercially available treatment in the United States for patients with late-onset Pompe disease was administered June 16 at the University of Florida.Pompe disease is a rare f” View full resource at medicalnewstoday.com
Most Recently Shared on June 17, 2010 at 2:56 pm By:
Start Of New Therapy For Late-Onset Pompe Patients In US: The first commercially available treatment in the United... http://mnt.to/f/3F2n
Lumizyme approved for Pompe disease - MPR
empr.com — “Genzyme announced the FDA approval of Lumizyme (alglucosidase alfa), a lysosomal glycogen-specific enzyme, for the treatment of patients 8 years of age with late (non-infantile) onset Pompe disease (acid -glucosidase (GAA) deficiency) who do not have evidence of cardiac hypertrophy” View full resource at empr.com
Most Recently Shared on May 25, 2010 at 5:40 pm By:
MPR News: Lumizyme approved for Pompe disease: Genzyme announced the FDA approval of Lumizyme (alglucosidase alfa)... http://bit.ly/d9RDQi
Lumizyme approved for Pompe disease - MPR
empr.com — “Genzyme announced the FDA approval of Lumizyme (alglucosidase alfa), a lysosomal glycogen-specific enzyme, for the treatment of patients 8 years of age with late (non-infantile) onset Pompe disease (acid -glucosidase (GAA) deficiency) who do not have evidence of cardiac hypertrophy” View full resource at empr.com
Most Recently Shared on May 25, 2010 at 5:44 pm By:
Lumizyme approved for Pompe disease: Genzyme announced the FDA approval of Lumizyme (alglucosidase alfa), a lysoso... http://bit.ly/c4DNLj
Lumizyme approved for Pompe disease - ONA
oncologynurseadvisor.com — “Genzyme announced the FDA approval of Lumizyme (alglucosidase alfa), a lysosomal glycogen-specific enzyme, for the treatment of patients 8 years of age with late (non-infantile) onset Pompe disease (acid -glucosidase (GAA) deficiency) who do not have evidence of cardiac hypertrophy” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 25, 2010 at 8:42 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Lumizyme approved for Pompe disease http://goo.gl/fb/sTmoX
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Susan S
Mom working in health content publishing field. Enjoy sharing information for healthy living.
-
Susan S
Mom working in health content publishing field. Enjoy sharing information for healthy living.
-
Susan S
Mom working in health content publishing field. Enjoy sharing information for healthy living.
Advertisement
